In some promising news, results of a major clinical trial in US have shown that patients who were administered antiviral drug Remdesivir recovered about 30% faster than those on placebo. This is the first time any medication has been shown to improve outcomes against the Covid-19 illness. The results also suggested that people who were on the drug were less likely to die, although the difference was small. Anthony Fauci, who heads the US National Institute of Allergy and Infectious Diseases (NIAID), which oversaw the trial, said, the data shows that Remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery." President Donald Trump said he was in support of doctors in prescribing it more widely.